One week left to apply for the HTRS Trainee Workshop Spring 2026!
Apply by Dec 15, 2025: www.htrs.org/continuing-p...
We are excited to welcome thirty medical trainees to Orlando, Florida, for the HTRS Trainee Workshop: Winter 2025. This year’s cohort will have the opportunity to learn from our distinguished faculty through an engaging and immersive program.
🌍 Reminder: ASH International Outreach Initiative Applications Now Open!
The ASH IOI aims to bridge the gap in #hematology education by offering free educational resources to institutions in low- and middle-income countries.
🔗 https://bit.ly/4liN3yc
#HemeSky #MedSky
PCP has pt on 4 agents for sleep/RLS…has never checked iron…ferritin of 6…what are we doing chat
🚨Abstract submissions for EAHAD 2026 are now open! Share your research with leading experts in haemophilia and bleeding disorders before 27 October ➡️
Pass the hematology boards with flying colors! 💫
Join the ASH Hematology Review Series for expert lectures and live sessions until October 6. Enroll today: https://bit.ly/3RR5bCN
#ABIM #HemeSky #MedSky #BoardExamsPrep
Heme fellows apply! Networking and career mentorship !
#hemesky #meded
Good news! The Senate’s leadership is proposing a $400M NIH funding increase for FY26. Now ASH urges the House to support the Senate numbers. ASH can’t do it alone—join the #Fight4Hematology: call, email, or meet with your Rep today. 🔗 https://bit.ly/3YeapvY
It looks like there is an error- the answer should be D :)
Interested in a mentor to guide your career in malignant hematology? Apply for the ASH’s new Mentorship Program, and grow your network! Deadline: Sept 26. Apply today! 🔗 https://bit.ly/3IPWjMA
Interested in becoming a mentor? Sign up today: https://bit.ly/3U5tm1t
#HemeSky
So impressed at the increased support the American Society of Hematology is planning for trainees and early-career investigators!! At some point, someone invested in us. Now it’s our turn. #Fight4Hematology and secure the future of hematology research. Donate! #hemesky www.hematology.org/foundation
💡An exciting illustrated review of "Gene-based therapies for hemophilia," by Wolfgang Miesbach et al is now available as full-OA article in @isth.org @rpth.bsky.social!
It provides a compreh. overview of #genetherapy for #hemophilia A & B, highlighting recent advances in patient care.
bit.ly/40RHmQ8
Immune thrombotic thrombocytopenic purpura (iTTP) is a rare immune-mediated disorder characterized by thrombocytopenia and microangiopathic hemolytic anemia, potentially causing life-threatening thrombosis.
Learn more in this Review.
https://ja.ma/4krNDZU
Meta-analysis on GLP-1RA (vs. placebo) and VTE:
🔹 PE rates significantly lower 📉
🔹 VTE rates lower but not statistically significant
🔹 No difference in DVT
🔹 Study design matters: RCTs vs. observational data
Accepted for publication in JTH!
#ISTH2025 #VTE #GLP1RA #Thrombosis
@jthjournal.bsky.social
This is what we were waiting for. A direct comparison between apixaban and rivaroxaban for the treatment of acute VTE. Apixaban reduces bleeding risk in the first 3 months by >50%!
Practice changing investigator-initiated RCT.
#ISTH2025
Day 3 of #ISTH2025 with the Hopkins Complement Crew #hemesky
Why is managing hypertensive disorders during pregnancy challenging? Tune in with Drs. Richard Burwick and Shruti Chaturvedi for a new HemeTalks episode for insights on pre-eclampsia, diagnostic tests, and management strategies! 🎧 https://bit.ly/3XwnXCD
#HemeSky @ash.edu.hematology.org
Updated Guidelines in TTP treatment just dropped at #ISTH2025
pubmed.ncbi.nlm.nih.gov/40533296/
Why do some people with the Duffy null phenotype have an ANC below most institutional reference ranges? Explore the mechanism behind this phenomenon 👇
Learn more: www.hematology.org/e...
#DuffyNull #HemeSky #MedSky #DANC #ASHEducation @ash.edu.hematology.org
Platelet refractoriness describes a poor response to platelet transfusion, and conventional thinking has divided etiologies into 2 broad categories: immune and nonimmune. buff.ly/JEfMzzB #hemesky #transfusionmedicine #HowITreat
#ASHSlideSaturday 🩸: Examine the slide from the #ASHImageBank. Identify the cells and where you may see them.
Tune in tomorrow for the answer!
#ASHEducation #Microlearning #MedEd #Hemesky #Hematology #Hematologist #MedicalEducation #TIL
Super amazing opportunity for students and trainees interested in hematology! #MedSky
The entire CDC lead program has been eliminated.
Lead exposure can lead to many issues including anemia & irreversible brain damage in young children.
It was <10 years ago we learned that 99,000 people in Flint Michigan had been exposed.
If only eliminating programs eliminated the risk.
Mild neutropenia may not need a bone marrow biopsy….
DANC can be diagnosed with just a quick easy blood test!
Now the D-team has chainsawed the CDC Division of Blood Diseases...
Thanks @ash.hematology.org 90+ other organizations for speaking up!
This action has immediate harms to the health of Americans.
www.medpagetoday.com/hematologyon...
Super exciting results regarding extended dose reduction of Apixaban in cancer- associated VTE #hemesky
www.nejm.org/doi/full/10....
If you are a healthcare provider and EVER draw labs to evaluate for iron deficiency you should know
-ferritin is best unless ongoing inflammation
-serum iron is USELESS
-a single digit ferritin result is NEVER NORMAL even if your lab says it is
#MedSky
Have you put in your application for the ASH Trainee Council? Open for just 6 more days! Med students, international trainees, PhD students and post docs, residents, fellows - you are eligible!
www.hematology.org/education/tr...
❓Are you ready for #Hemophilia rebalancing therapies?
💡Join the @isth.org webinar on how to assess emerging rebalancing therapies & prepare treatment teams for their use
🎙️Speakers: Speaker(s): Amy Shapiro, Stacy Croteau
🗓️Feb. 26, 2025 15:00 PM UTC
👉https://buff.ly/3E77Apo
